RecruitingNCT06637137

Patient Blood Management in Patients Scheduled for Cardiac Surgery

Patient Blood Management in Cardiac Surgical Patients: the ICARUS-2 Study


Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment

464 participants

Start Date

Feb 24, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The ICARUS 2 study has the general objective of collecting data in patients undergoing cardiac surgery; in our centre, in order to optimize and improve hemoglobin values, a team of haematologists, assisted by cardio anesthetists and cardiac surgeons, will evaluate the blood tests of patients scheduled for elective cardiac surgery in order to correct any states of hypoferritinemia (low iron in the blood) to promote recovery from blood losses related to cardiac surgery. This objective is strongly encouraged by the good use of blood programs currently in force at our foundation. In particular, the research presented here intends to demonstrate a reduction in the number of intra- and post-operative transfusions.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • \- all adult patients scheduled for elective cardiac surgery

Exclusion Criteria3

  • pregnancy
  • dyalisis
  • patient's refusal

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGIron

Patients who present a state of hypoferritinemia or a state of reduced transferrin saturation will undergo administration of i.v iron at least 2 weeks before scheduled cardiac surgery, plus acid folic and B vitamin co-administration.


Locations(1)

Fondazione Policlinico Gemelli IRCCS

Roma, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06637137


Related Trials